Format

Send to

Choose Destination
Hepatology. 2019 Oct 29. doi: 10.1002/hep.31010. [Epub ahead of print]

Letter to the Editor: Glucocorticosteroids for alcoholic for alcoholic hepatitis.

Author information

1
Sechenov University, Centre for Evidence-Based Medicine, Moscow, Russian Federation.
2
Rigshospitalet, Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Copenhagen, Denmark.
3
Ulyanovsk State Clinical Hospital, Gastroenterology, Ulyanovsk, Russian Federation.
4
Università degli Studi di Milano, Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Milan, Italy.

Abstract

Our Cochrane systematic review on glucocorticosteroids versus placebo or no intervention for people with alcoholic hepatitis found no evidence of a difference on clinically important outcomes at either of the three timepoints of follow-up.(4) Our review (last search 18.01.2019) was based on a pre-published, peer-reviewed protocol. In a subgroup meta-analysis of 14 trials with 1679 participants with severe alcoholic hepatitis, we found no evidence of effect of glucocorticosteroids on mortality.(4).

PMID:
31660631
DOI:
10.1002/hep.31010

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center